Pfizer-BioNTech to Seek Approval to Vaccinate 5-Year-Olds

BioNTech, the vaccine maker collaborating with Pfizer, is set to seek worldwide approval for its COVID-19 vaccine for children between the ages of 5 and 11 within the coming weeks, according to company executives.

“Already over the next few weeks, we will file the results of our trial in five to 11-year olds with regulators across the world and will request approval of the vaccine in this age group, also here in Europe,” Chief Medical Officer Oezlem Tuereci told Der Spiegel, according to Reuters.

Read More

Virginia Hospitals Receive First Shipments of COVID-19 Vaccine

The coronavirus vaccine has finally arrived in the Commonwealth of Virginia.

Several hospitals in Virginia received initial shipments of the newly approved Pfizer-BioNTech COVID-19 vaccine this week, kicking off the state’s months-long plan for mass vaccinations and finally signaling a potential end to the pandemic.

Read More

Tennessee Receives First Shipment of COVID-19 Vaccine, But No Doses Administered

A first shipment of 975 doses of the Pfizer-BioNTech COVID-19 vaccine arrived in Tennessee on Monday, but there are no plans to administer the vaccine until larger shipments arrive to hospitals on Thursday.

Instead, the early shipment of the vaccine will be held “as an emergency backup supply, should any receiving hospital’s supply be damaged,” the Tennessee Department of Health announced Monday.

Read More